to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Douglas Crawford of QB3 moderated a therapeutics funding panel at a recent Life Science Ventures Summit hosted by the Kauffman Foundation. Crawford focused a majority of the discussion on pitch strategies with Allan May, Karl Handelsman and Jesus Soriano
See who made this week's 6 to follow
The United States is joining the rest of the world in its approach to patent filings. But what does that mean in the completely global world of medical and pharmaceutical treatments, therapies and technologies depending on a strong and reliable patent system? Read how new American patent law will change medical business plans.
Physician-consultants and medical device startups often don’t realize that failure to draft a tight physician-consultant contract could result in violations of federal laws and criminal and civil penalties. Read more about the guidelines for these contracts.
How will medtech and biotech companies be affected by the recently approved Leahy-Smith America Invents Act? Read more for five things these companies need to know about the modernized patent laws.
Medical device startups could reap the benefits of patent reform, especially the shorter regulatory approval process that would allow companies to get their patents faster. Read more about the changes ahead for patent seekers.
At this week's Biotech 2011 conference, speakers from Teva Pharmaceutical Industries and Merck spoke about how biotech companies can survive in this tough regulatory and economic environment.
Despite having a great product, your company can suffer from mistakes made during the product launch. Here are five tips on avoiding the mistakes others have made.
There is no shortage of well-educated people in academic environments. But the challenge is in turning the attention of those bright minds to entrepreneurship. Here are a few ideas on how to do it.
Venture firms are approaching angel investor groups to co-invest at the growth stage of startups. Read more about the impact this could have on startup health IT companies.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.